The oncology adjuvants market is expanding due to rising cancer rates, personalized medicine demand, and advances in ...
Adam Christman, DVM, MBA: Okay, so 5 common oncology mistakes from Dr Venable. I'm really curious to hear these. So let's ...
Community-based CAR T-cell therapy improves access, reducing travel burdens and hospital admissions for patients with blood ...
Data update from vopimetostat (TNG462) showed 2L MTAP-del pancreatic cancer median progression free survival (mPFS) 7.2 ...
Asahi Kasei, a global provider of healthcare and pharmaceutical solutions, announced that Nefecon (marketed in the United States as TARPEYO® (budesonide) delayed release capsules), has been included ...
Calliditas Therapeutics (Calliditas), an Asahi Kasei company, announced today that new data will be presented at the 2025 American Society of Nephrology Kidney Week, taking place from November 6 to 9 ...
Treatment innovations in advanced lung cancer and melanoma over the past 2 decades have significantly improved OS, but they ...
The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...
November is Pet Cancer Awareness Month. Now is the time to check pets for early signs of cancer and speak to a vet if ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback